Page results
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
Information about Magnetic Resonance Imaging (MRI) scans at UCLH.
-
Information about Lutetium-177 PSMA radionuclide therapy for metastatic or treatment-resistant prostate cancer
-
Gastro-oesophageal reflux (GOR) is the effortless regurgitation of feeds/milk. It affects over 40% of babies.
-
The Royal National Ear Nose and Throat Hospital is a national and international centre for voice disorders. The voice service includes four consultant laryngologists, eight speech and language therapists and specialist nurses.
-
Our vascular service has a major emphasis on endovascular (minimally invasive) treatments for vascular diseases, and this approach has largely replaced conventional open vascular surgery at UCLH.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
Dr Nagendran is a consultant neurophysiologist eripheral nerve and muscle disease, skeletal muscle channelopathies, nerve excitability disorders
-
A clinic for neurology patients with long COVID
File results
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
-
FOI/2022/0230 - Fabry, Gaucher and Pompe diseases drug treatments
-
FOI/2022/0232 - Number of patients who have died while waiting for elective care
-
FOI/2022/0233 - Diagnosis/ treatment of epilepsy, dravet syndrome, lennox gastaut syndrome and tuberous sclerosis complex
-
FOI/2022/0236 - Video communication software licences